Currently Enrolling
Trial Physician / Study Coordinator
Joel Brune
Email PhoneSite Name
Washington University
660 South Euclid Ave CB 8126 St. Louis, MO 63110
Find other locations for this trial:
Currently Enrolling
Eligibility Criteria
About the Drug
What is involved for the patient
Target Enrollment
450 patients globally
Estimated End Date
January 2025